Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

F.D.A. Experts Will Vote on a Cure for Sickle Cell Disease

The treatment from the company Vertex would be the first medicine to use the gene editing tool CRISPR.

Gina Kolata
Author: Gina Kolata

Written by

Gina Kolata

in

Crispr (DNA), CRISPR Therapeutics, Drugs (Pharmaceuticals), Food and Drug Administration, Genetic Engineering, Sickle Cell Anemia, Therapy and Rehabilitation, Vertex Pharmaceuticals Inc
←Ex-North Dakota Lawmaker Accused Of Flying To Prague To Rape Minor
X Says It Is Worth $19 Billion, Down From $44 Billion Last Year→

More posts

  • Zhu Rongji, Former Premier Who Pushed China to a Market Economy, Dies at 97

  • Ariana Grande Spotted For First Time Since Announcing Plans To Step Back From Public Life

  • Six things to know about Marco Rubio’s joint interview with wife Jeanette on Katie Miller’s podcast

  • Lindell hits snooze on primary loss; progressive steam stalls

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube